CAS: 53-85-0; (2R,3R,4S,5R)-2-(5,6-Dichloro-1H-Benzo[d]Imidazol-1-yl)-5-(Hydroxymethyl)Tetrahydrofuran-3,4-Diol

该化合物是经过修改的核素派衍生物,作为有机合成和制药研究的宝贵中间体; 其核仁核素核心,加上肋骨功能,使它成为开发核素类的多功能构件,具有潜在的生物活动; 二氯代用品增强了其反应性,能够有选择地修改定向应用; 该化合物在医药化学中特别有助于探索抗病毒剂或抗癌剂,因为它在结构上与天然核素相似; 其定义明确的化学特性和稳定性确保合成工作流程的一贯性; 研究人员在复杂的分子设计中将这种化合物的纯度和可靠性视为有价值的.

结构式图片

相似化合物

176161-18-5 728-01-8 132-13-8

上下游产品

CAS号6478-73-5 5,6-二氯苯并咪唑 | CAS号5348-42-5 4,5-二氯-1,2-苯二胺 | CAS号19462-98-7 5.6-二氯-2-巯基苯并咪唑 | CAS号142356-78-3 5,6-dichloro-1-... | CAS号6974-32-9 1-乙酰氧基-2,3,5-三苯...

合成工艺路线路线简述

    4,5-二氯邻苯二胺置于氢氧化钾,Ammonium Hydroxide,三氟甲磺酸三甲基硅酯,氨,镍,牛血清白蛋白体系中,用 乙醇,水,乙腈 作为反应溶剂,化学反应 65.25H,反应生成 5,6-二氯-1-β-D-呋喃核糖基苯并咪唑
    参考文献:Benzimidazole Ribonucleosides: Design,Synthesis,And Antiviral Activity Of Certain 2-(Alkylthio)-And 2-(Benzylthio)-5,6-Dichloro-1-(.Beta.-D-Ribofuranosyl)Benzimidazoles
    标题:Benzimidazole Ribonucleosides: Design,Synthesis,And Antiviral Activity Of Certain 2-(Alkylthio)-And 2-(Benzylthio)-5,6-Dichloro-1-(.Beta.-D-Ribofuranosyl)Benzimidazoles
    摘要:Several 2-Alkylthio-And 2-Benzylthio Derivatives Of 5,6-Dichloro-1-(Beta-D-Ribofuranosyl)Benzimidazole (Drb) Have Been Designed And Synthesized From 5,6-Dichloro-1-(Beta-D-Ribofuranosyl)-Benzimidazole-2-Thione. All Compounds Were Evaluated For Activity Against Human Cytomegalovirus (Hcmv) And/or Herpes Simplex Virus Type-1 (Hsv-1). Three Different Cytotoxicity Assays Were Used To Determine If The Compounds Were Toxic To Uninfected Cells. Most Of The 2-Alkylthio Compounds Were Either Inactive Against Hcmv And Hsv-1 Or Were Active Only At Concentrations At Or Near Those Which Produced Toxicity In Uninfected Cells. The Best Separation Between Activity Against Hcmv And Cytotoxicity Was Observed With The 2-Benzylthio Analog 7. This Prompted Us To Synthesize The Substituted 2-Benzylthio Analogs 11-23 Using A Topliss Tree Approach. None Of These Compounds Were More Active Than Compound 7; Most Of The Analogs Were Weakly Active Against Both Hcmv And Hsv-1,But The Activity Was Not Separated From Cytotoxicity. On The Basis Of Both Antiviral And Cytotoxicity Data,Compound 7 Was The Best Compound In The Series. It Was More Active Against Hcmv Than Drb (The 2-Unsubstituted Analog),Acyclovir,And Foscarnet,But It Was Less Active Than Ganciclovir.
    DOI:10.1021/jm00044A015

    海关参考信息

    专利信息


    专利号:US-8673594-B2
    优先权日:2000-05-05
    标题:Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis
    发明人:FILBIN MARIE T; RATAN RAJIV R
    权利人:FILBIN MARIE T; RATAN RAJIV R; RES FOUNDATION OF CITY UNIVERSITY OF NEW YORK; BETH ISRAEL DEACONNESS MEDICAL CT
    摘要:This invention relates to the novel identification of arginase as an enzymatic activity which can reverse inhibition of neuronal regeneration in the central and peripheral nervous system. Assays to monitor the effects of various agents on arginase expression and thus on neuronal regeneration and repair and to identify agents which will block or promote the inhibitory effects on neuronal outgrowth are provided. This invention also relates to compositions and methods using agents that can reverse the inhibitory effects of myelin on neural regeneration by affecting arginase activity or putrescine and derivative polyamine levels in a neuron. Methods for regulating and for promoting (or repressing) neuronal growth or regeneration in the nervous system, methods for treating injuries or damage to nervous tissue or neurons, and methods for treating neural degeneration associated with conditions, disorders or diseases, comprising the step of administering at least one of the compositions according to this invention, are provided.

    专利号:US-4482708-A
    优先权日:1982-08-09
    标题 :3', 5'-Dinucleoside phosphates of 5,6-dichloro-1-β-D-ribofuranosyl-1-benzimidazole and methods of making and using the same
    发明人:NGUYEN NICOLAS C
    权利人:NGUYEN NICOLAS C
    摘要:A new 3',5'-dinucleoside phosphate, the pharmaceutically acceptable salts thereof and intermediates therefor. The 3',5'-dinucleoside phosphate of 5,6-dichloro-1- beta -D-ribofuranosyl-1-benzimidazole and namely 5,6-dichloro-1- beta -D-ribofuranosyl-1-benzimidazole-3'-yl-5,6-dichloro-1- beta -D-ribofuranosyl-1-benzimidazole-5'-yl-phosphate possesses potent inducing activity for the cellular synthesis of interferons and in particular beta -interferon. The compound is also markedly effective to induce antiviral levels of interferon and possesses significant interferon potentiation properties. The invention also contemplates methods for the preparation of the new compounds and for using the new 3',5'-dinucleoside phosphate.

    专利号:US-10059780-B2
    优先权日:2015-06-30
    标题:Method for producing rubber particles with reduced coagulation tendency, method for producing pneumatic tire, and method for producing rubber product
    发明人:YAMAGUCHI HARUHIKO; INOUE Yukino; FUSHIHARA KAZUHISA; TAKAHASHI SEIJI; YAMASHITA SATOSHI; NAKAYAMA TORU
    权利人:SUMITOMO RUBBER IND; UNIV TOHOKU
    摘要:Provided is a method for producing rubber particles with a reduced coagulation tendency. The present invention relates to a method for producing rubber particles with a reduced coagulation tendency, the method including a step of performing protein synthesis in the presence of both rubber particles and a cell-free protein synthesis solution containing an mRNA coding for a rubber elongation factor (REF) family protein to bind the REF family protein to the rubber particles.

    专利号:US-10227344-B2
    优先权日:2016-06-24
    标题 :CK2 inhibitors, compositions and methods thereof
    发明人:WEBBER STEPHEN E; TAO XUELIANG; BRIN ELENA
    权利人:POLARIS PHARMACEUTICALS INC
    摘要:The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula (I), or a stereoisomer, a tautomer or a pharmaceutically acceptable salt thereof. n nFor Formula (I) compounds R 1 , R 2 , R 3 , Ar and Z are as defined in the specification. The inventive Formula (I) compounds are inhibitors of CK2 and find utility in any number of therapeutic applications, including but not limited to treatment of proliferative disorders such as cancer, inflammation and immunological disorders.

    专利号:US-10907179-B2
    优先权日:2015-06-30
    标题:Production method for polyisoprenoid, vector, transgenic plant, production method for pneumatic tire, and production method for rubber product
    发明人:YAMAGUCHI HARUHIKO; INOUE Yukino; FUSHIHARA KAZUHISA; TAKAHASHI SEIJI; YAMASHITA SATOSHI; NAKAYAMA TORU
    权利人:SUMITOMO RUBBER IND; UNIV TOHOKU
    摘要:The present invention provides a method for producing a polyisoprenoid with which it is possible to enhance the rubber synthesis activity of rubber particles to increase natural rubber production. The present invention relates to a method for producing a polyisoprenoid in vitro, which involves the use of a gene coding for a cis-prenyltransferase (CPT) family protein and a gene coding for a Nogo-B receptor (NgBR) family protein, and further involves the use of rubber particles bound to proteins encoded by these genes; or a method for producing a polyisoprenoid, which includes introducing into a plant a vector in which a promoter having a promoter activity that drives laticifer-specific gene expression is linked to a gene coding for a CPT family protein and a gene coding for a NgBR family protein, to express proteins encoded by the genes specifically in laticifers.
    上海三牧化工技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.synmedia-chem.com
    企业联系电话:021-38681880👤
    📞上海三牧化工技术有限公司 ⚠️参考联系方式
    联系人:徐小波
    电话:021-38681880
    手机:13817889927
    传真:021-33908196
    邮箱:peter.xu@synmedia-chem.com
    通信地址: 上海市浦东新区合庆镇瑞庆路526号张江高科东区医疗产业园3幢2层
    邮编: 201201
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市浦东新区合庆镇瑞庆路526号张江高科东区医疗产业园3幢2层
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Rickert P, Et Al. Cyclin C/cdk8 And Cyclin H/cdk7/p36 Are Biochemically Distinct Ctd Kinases. Oncogene. 1999 Jan 28;18(4):1093-102.
    [参考文献]: Schang Lm. Cyclin-Dependent Kinases As Cellular Targets For Antiviral Drugs. J Antimicrob Chemother. 2002 Dec;50(6):779-92.
    [参考文献]: Te Poele Rh, Et Al. Rna Synthesis Block By 5, 6-Dichloro-1-Beta-D-Ribofuranosylbenzimidazole (Drb) Triggers P53-Dependent Apoptosis In Human Colon Carcinoma Cells. Oncogene. 1999 Oct 14;18(42):5765-72.
    [参考文献]: Yankulov K, Et Al. The Transcriptional Elongation Inhibitor 5,6-Dichloro-1-Beta-D-Ribofuranosylbenzimidazole Inhibits Transcription Factor Iih-Associated Protein Kinase. J Biol Chem. 1995 Oct 13;270(41):23922-5.
    [参考文献]: Zandomeni Ro. Kinetics Of Inhibition By 5,6-Dichloro-1-Beta-D-Ribofuranosylbenzimidazole On Calf Thymus Casein Kinase Ii. Biochem J. 1989 Sep 1;262(2):469-73.

    合成参考文献


    参考文献:10.1016/j.bbrc.2023.08.050
    摘要:Ikeda Y, Davis MI, Sumita K, Zheng Y, Kofuji S, Sasaki M, Hirota Y, Pragani R, Shen M, Boxer MB, Takeuchi K, Senda T, Simeonov A, Sasaki AT. Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells. Biochemical and Biophysical Research Communications. 2023 Oct;679():116–21. doi: 10.1016/j.bbrc.2023.08.050.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知